Empowered Funds
HCAT icon

Empowered Funds’s Health Catalyst HCAT Stock Holding History

Empowered Funds’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$137K Buy
+79,195
New +$151K ﹤0.01% 2364

Other funds holding HCAT

CF
CDC Financial Chicago, Illinois $209M AUM 26.53% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $13B AUM 14.15% 1-Year Est. Return
Nepsis Inc
Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $212M AUM 53.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
HRT Financial
HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return

Empowered Funds's HCAT Position: Q3 2026 in Review

Empowered Funds opened a new position in Health Catalyst (HCAT) in Q3 2026: 79,195 shares worth $137K. The stake represents ﹤0.01% of the portfolio and ranks #2364 among its holdings.

76 funds tracked by Wall St. Rank hold HCAT as of Q3 2026.

  • Empowered Funds held 79,195 shares of Health Catalyst worth $137K as of Q3 2026.
  • Health Catalyst was a new Empowered Funds position in Q3 2026.
  • Health Catalyst made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2364 holding.
  • 76 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.